Concord Biotech Limited (NSE: CONCORDBIO)
1,835.90
-17.80 (-0.96%)
Sep 6, 2024, 3:30 PM IST
Concord Biotech Revenue
Concord Biotech had revenue of 2.16B INR in the quarter ending June 30, 2024, with 10.77% growth. This brings the company's revenue in the last twelve months to 10.38B, up 19.71% year-over-year. In the fiscal year ending March 31, 2024, Concord Biotech had annual revenue of 10.17B with 19.20% growth.
Revenue (ttm)
10.38B
Revenue Growth
+19.71%
P/S Ratio
18.50
Revenue / Employee
7.54M
Employees
1,377
Market Cap
192.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 10.17B | 1.64B | 19.20% |
Mar 31, 2023 | 8.53B | 1.40B | 19.67% |
Mar 31, 2022 | 7.13B | 959.91M | 15.56% |
Mar 31, 2021 | 6.17B | 1.05B | 20.42% |
Mar 31, 2020 | 5.12B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries Limited | 9,252.89B |
Tata Consultancy Services Limited | 2,441.25B |
HDFC Bank Limited | 2,663.37B |
Bharti Airtel Limited | 1,510.49B |
ICICI Bank Limited | 1,686.78B |
Infosys Limited | 1,555.41B |
State Bank of India | 3,319.63B |
Hindustan Unilever Limited | 621.07B |